Bio-Techne SEC filings, summarized
We read every Bio-Techne 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track TECH in your inbox
Add Bio-Techne to your watchlist — free, every morning.
Recent filings
BIO‑TECHNE ($TECH) filed an 8‑K on Feb 11, 2026 disclosing an Executive Employment Agreement with Steve…
BIO‑TECHNE ($TECH) filed an 8‑K on Feb 11, 2026 disclosing an Executive Employment Agreement with Steve Crouse dated Feb 10, 2026 (Exhibit 10.1). Investors…
Bio‑Techne Corp filed Form 8‑K (Item 8.01) on Feb 11, 2026 — a press release was attached as Exhibit 99.1.
Bio‑Techne Corp filed Form 8‑K (Item 8.01) on Feb 11, 2026 — a press release was attached as Exhibit 99.1. 📢 $TECH #SECfiling #BioTech Press release issued…
$TECH: Dr.
$TECH: Dr. Matt McManus will transition from President, Diagnostics & Spatial Biology effective Mar 1, 2026; Board approved his termination on Feb 9, 2026.…
BIO‑TECHNE filed an 8‑K on Feb 4, 2026 attaching a press release (Ex.
BIO‑TECHNE filed an 8‑K on Feb 4, 2026 attaching a press release (Ex. 99.1) announcing results of operations—see the Feb 4 release for revenue/earnings…
Bio-Techne ($TECH) announced a cash dividend via press release dated Feb 4, 2026.
Bio-Techne ($TECH) announced a cash dividend via press release dated Feb 4, 2026. The press release is attached to the 8-K as Exhibit 99.2. 📢💰 #dividend…
Bio‑Techne ($TECH) issued a press release on Feb 4, 2026 reporting results for the quarter and six months…
Bio‑Techne ($TECH) issued a press release on Feb 4, 2026 reporting results for the quarter and six months ended Dec 31, 2025 and its financial condition as…